Minaris Regenerative Medicine is a global leading Contract Development and Manufacturing Organization (CDMO) specializing in cell and gene therapy products. With over 20 years of experience, they offer high-value clinical and commercial manufacturing services, development solutions, and technologies to clients worldwide.
With state-of-the-art facilities in North America, Europe, and Asia, Minaris Regenerative Medicine is dedicated to pushing the boundaries of medicine and creating future cell therapy miracles. Their expertise in manufacturing processes and their track record of successful technology transfers make them a valuable partner for therapeutic programs.
Generated from the website